Potent, orally bioavailable HIV-1 protease inhibitors containing noncoded D-amino acids
- 7 December 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (23) , 2897-2902
- https://doi.org/10.1016/0960-894x(95)00508-q
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Targeting HIV-1 protease: A test of drug-design methodologiesTrends in Pharmacological Sciences, 1995
- New dipeptide isosteres useful for the inhibition of HIV-1 proteaseBioorganic & Medicinal Chemistry Letters, 1994
- D-amino acids as novel P2/P3 ligands for inhibitors of HIV-1 proteaseBioorganic & Medicinal Chemistry Letters, 1994
- Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostereJournal of Medicinal Chemistry, 1993
- Design and implementation of a particle concentration fluorescence method for the detection of HIV-1 protease inhibitorsAnalytical Biochemistry, 1992
- The HIV-1 Protease as a Therapeutic Target for AIDSAIDS Research and Human Retroviruses, 1992
- Ro-31-8959/003Drugs of the Future, 1991
- Rational Design of Peptide-Based HIV Proteinase InhibitorsScience, 1990
- Mechanism of formation of serine β-lactones by Mitsunobu cyclization: synthesis and use of L-serine stereospecifically labelled with deuterium at C-3Canadian Journal of Chemistry, 1986
- Conversion of serine to stereochemically pure .beta.-substituted .alpha.-amino acids via .beta.-lactonesJournal of the American Chemical Society, 1985